Shelton Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Shelton Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,132	Closed	-$427K	–	848
2020 Q3	$427K	Hold	8,132	–	–	0.02%	458
2020 Q2	$271K	Sell	8,132 -1,284	-14%	-$40.9K	0.01%	483
2020 Q1	$256K	Buy	+9,416	New	+$262K	0.02%	454
2018 Q4	–	Sell	-7,785	Closed	-$205K	–	920
2018 Q3	$205K	Buy	+7,785	New	+$210K	0.01%	858

Shelton Capital Management's MNTA Position: Q4 2020 in Review

Shelton Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 8,132 shares — an estimated $427K sold.

Shelton Capital Management first reported a position in MNTA in Q3 2018 and held it in 4 quarters. The position peaked at $427K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Shelton Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Shelton Capital Management sold 8,132 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $427K.
Shelton Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2018 and held it in 4 quarters.
Shelton Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $427K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Shelton Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.